Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rizzi

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|April 26, 2021
Motion-induced inertial effects and topological phase transitions in skyrmion transportA W Teixeira, S Castillo-Sepúlveda, L G Rizzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
European Journal of Heart Failure|April 29, 2025
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathyMartina Setti, Manuela Iseppi, Job A J Verdonschot, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|April 26, 2021
Motion-induced inertial effects and topological phase transitions in skyrmion transportA W Teixeira, S Castillo-Sepúlveda, L G Rizzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
European Journal of Heart Failure|April 29, 2025
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathyMartina Setti, Manuela Iseppi, Job A J Verdonschot, et al.
Pageof 8